NWPF

News Archives

Filtered by: January 2012

Few Parkinson's patients enroll in trials; Michael J. Fox aims to change that

Monday January 30, 2012

When Linda Morgan was diagnosed with Parkinson’s disease in October 2005, her doctor told her that her symptoms weren’t bad and instructed her to come back in a year.

Read Article

Scientists identify protein that contributes to symptoms of Parkinson's disease

Wednesday January 25, 2012

Scientists at the Gladstone Institutes, an independent and nonprofit biomedical-research organization, have identified a protein that exacerbates symptoms of Parkinson's disease—a discovery that could one day lead to new treatments for people who suffer from this devastating neurodegenerative illness.

Read Article

Mesa Musings: Ali inspires my fight with Parkinson's

Wednesday January 25, 2012

Several nights ago I dreamed I met heavyweight boxing champ and cultural icon, Muhammad Ali.

He turned 70 last week.

Though I've been a fan for decades, I confess I've never dreamed of him before.

Read Article

Mediterranean diet 'halves risk of Parkinson's disease'

Monday January 23, 2012

A Mediterranean-style diet rich in fruit, vegetables and fish can almost halve the risk of Parkinson's disease, according to new research.

Read Article

Parkinson's Alley

Monday January 23, 2012

Recent studies have found statistical links between pesticide use and an outbreak of Parkinson's disease in California farm towns. Researchers even know which chemicals are the likely culprits. What's the government doing about it?

Read Article

Psychiatric Treatment Crucial for Many Parkinson’s Patients

Monday January 23, 2012

A decade or so ago, psychiatrists would have been hard pressed to provide evidence-based psychiatric treatments to Parkinson’s patients. Thanks to research advances, that situation has improved considerably.

Read Article

Amarantus BioSciences Licenses Parkinson's Disease Diagnostic Biomarker Test from Power3 Medical Products

Monday January 23, 2012

UNNYVALE, Calif. & THE WOODLANDS, Texas, Jan 23, 2012 (BUSINESS WIRE) -- Amarantus BioSciences, Inc. AMBS , a biotechnology company developing MANF, a first-in-class disease--modifying therapeutic protein being developed for the treatment of Parkinson's Disease, today announced an exclusive worldwide license agreement with Power3 Medical Products, Inc. for the NuroPro(R) Blood Test as it relates to Parkinson's disease diagnosis. Concurrent with the license, Amarantus has raised $100,000 from a private, foreign investor introduced to the Company by www.tomorrowsbluechips.com .

Read Article

MSU researchers identify path to treat Parkinson’s disease at its inception

Tuesday January 17, 2012

Imagine if doctors could spot Parkinson’s disease at its inception and treat the protein that triggers it before the disease can sicken the patient.

Read Article

Deep Brain Stimulation Lessens Parkinson’s Symptoms

Tuesday January 17, 2012

Emerging research indicates that deep brain stimulation (DBS) can improve motor symptoms and enhance quality of life in patients with advanced Parkinson’s disease.

Read Article

Strength from Weakness

Tuesday January 17, 2012

In the living room of a lovely home at the end of an oak tree-lined lane in Hillsboro, Ore., Ben Petrick inserts a disc into the DVD player. His wife, Kellie, has taken their 4-year-old daughter, Makena, upstairs for a nap, giving Petrick the opportunity to flop into his easy chair and fast-forward to the moment he wants you to see.

Read Article
<< Back 1 - 10 of 24 Next >>

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement